Lucid Diligence Brief: Coultreon Biopharma Raises $125M for SIK3 Inhibitor
Lucid Diligence Brief: Coultreon Biopharma Raises $125M for SIK3 Inhibitor…
Vaccines Today—April 10, 2026
This week’s Vaccines update highlights clinical progress, early-stage trial…
Immunology Today—April 15, 2026
This week’s Immunology update highlights regulatory progress, clinical…
Immunology Today—April 8, 2026
This week’s Immunology update highlights regulatory and portfolio shifts, mid-…
Lucid Diligence Brief: Royalty Pharma and J&J partner in a $500M R&D deal for JNJ-4804
Lucid Diligence Brief: Royalty Pharma and J&J partner in a $500M R&D…
Lucid Diligence Brief: Quotient and MSD ink a $2.2 billion IBD drug discovery deal
Lucid Diligence Brief: Quotient and MSD ink a $2.2 billion IBD drug discovery…
Immunology Today—March 11, 2026
This week’s Immunology update highlights regulatory progress, positive…
Lucid Diligence Brief: Teva and Blackstone Life Sciences $400m duvakitug financing
Lucid Diligence Brief: Teva and Blackstone Life Sciences $400m duvakitug…
Lucid Diligence Brief: OSE Immunotherapeutics refocus on lusvertikimab and Tedopi
Lucid Diligence Brief: OSE Immunotherapeutics refocus on lusvertikimab and…
Immunology Video Recap—February 25, 2026
This biweekly Immunology video recap highlights key developments across…
Immunology Today—February 25, 2026
This week's Immunology update summarizes covering clinical-trial readouts and…
ECCO 2026 Preview: Key Crohn’s and Colitis Highlights to Watch
ECCO 2026 at a Glance Get ready for ECCO 2026. LucidQuest’s preview brings…